Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Alan Altraja"'
Autor:
Susanne Hansen, Anna von Bülow, Patrik Sandin, Olivia Ernstsson, Christer Janson, Lauri Lehtimäki, Hannu Kankaanranta, Charlotte Ulrik, Bernt Bøgvald Aarli, Hanna Fues Wahl, Kirk Geale, Sheila Tuyet Tang, Maija Wolf, Tom Larsen, Alan Altraja, Helena Backman, Maritta Kilpeläinen, Arja Viinanen, Dora Ludviksdottir, Paula Kauppi, Asger Sverrild, Sverre Lehmann, Vibeke Backer, Valentyna Yasinska, Tina Skjold, Jussi Karjalainen, Apostolos Bossios, Celeste Porsbjerg
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Background Real-life evidence on prevalence and management of severe asthma is limited. Nationwide population registries across the Nordic countries provide unique opportunities to describe prevalence and management patterns of severe asthma at popul
Externí odkaz:
https://doaj.org/article/53bc481cf3ba47f2b816ed9063f899ad
Autor:
Ott Kiens, Egon Taalberg, Viktoria Ivanova, Ketlin Veeväli, Triin Laurits, Ragne Tamm, Aigar Ottas, Kalle Kilk, Ursel Soomets, Alan Altraja
Publikováno v:
ERJ Open Research, Vol 9, Iss 1 (2023)
Background The apnoea–hypopnoea index (AHI) forms the basis for severity of obstructive sleep apnoea (OSA), a condition expected to reprogramme metabolic pathways in humans. We aimed to identify the AHI breakpoint from which the majority of signifi
Externí odkaz:
https://doaj.org/article/e7481e4c4d0849418390c126aa46a092
Autor:
Dzmitriy Zhurkin, Elmira Gurbanova, Jonathon R. Campbell, Dick Menzies, Svetlana Setkina, Hennadz Hurevich, Varvara Solodovnikova, Dzmitry Viatushka, Alan Altraja, Alena Skrahina
Publikováno v:
ERJ Open Research, Vol 8, Iss 2 (2022)
Bedaquiline is now considered a first-line medicine for treatment of rifampicin-resistant tuberculosis (RR-TB). We evaluated the safety of treatment with bedaquiline for longer than 190 days in individuals with RR-TB under programmatic conditions. In
Externí odkaz:
https://doaj.org/article/f96b8d3f622d45fd9570bfeec4316a7f
Autor:
Miriam Barrecheguren, Karen O'Hara, Marion Wilkens, Jeanette Boyd, Ewa Kolda, Beatriz Lara, Joanna Chorostowska-Wynimko, Ilaria Ferrarotti, Jan Chlumský, Christian Clarenbach, Timm Greulich, Marc Miravitlles, Maria Sucena, Members of EARCO CRC Timm Greulich (Germany, co-chair) Marc Miravitlles (Spain co-chair). Steering committee:, Joanna Chorostowska-Wymiko (Poland), Ilaria Ferrarotti (Italy), Noel G. McElvaney (Ireland), Karen O'Hara (UKpatients' representative), Jan Stolk (Netherlands), Robert A. Stockley, Alice Turner (UK), Marion Wilkens (Germany patients' representative), EARCO members:, Angelo Corsico, Luciano Corda (Italy), Maria Sucena (Portugal), Miriam Barrecheguren (Spain ERS early career representative), Cristina Esquinas (Spain), David Parr, Ravi Mahadeva (UK), Jan Chlumsky (Czech Republic), Sabina Janciauskiene, Robert Bals (Germany), Jens Ulrik Jensen (Denmark), Kostas Kostikas (Greece), Malcolm Kohler, Christian Clarenbach (Switzerland), Alan Altraja (Estonia), Wim Jenssens, Silvia Pérez-Bogerd (Belgium), Caroline Gouder (Malta), Ana Hecimovic (Croatia), Aleksandra Dudvarski (Serbia), Alvils Krams (Latvia), Ruxandra Ulmeanu, Ana Zaharie (Rumania), Jean-François Mornex (France), Arzu Yorgancioglu (Tukey), Karin Schmid-Scherzer (Austria), Hanan Tanash, Eeva Piitulainen (Sweden), Oleksandr Mazulov (Ukraine), Yavor Ivanov (Bulgaria)
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
α1-antitrypsin deficiency (AATD) is a rare and under-recognised genetic condition. Owing to its low prevalence, international initiatives are key for conducting high-quality research in the field. From July 2018 to December 2019, the European Alpha-
Externí odkaz:
https://doaj.org/article/3dc0881f12aa43ff84cc6643d3544e50
Autor:
Timm Greulich, Alan Altraja, Miriam Barrecheguren, Robert Bals, Jan Chlumsky, Joanna Chorostowska-Wynimko, Christian Clarenbach, Luciano Corda, Angelo Guido Corsico, Ilaria Ferrarotti, Cristina Esquinas, Caroline Gouder, Ana Hećimović, Aleksandra Ilic, Yavor Ivanov, Sabina Janciauskiene, Wim Janssens, Malcolm Kohler, Alvils Krams, Beatriz Lara, Ravi Mahadeva, Gerry McElvaney, Jean-François Mornex, Karen O'Hara, David Parr, Eava Piitulainen, Karin Schmid-Scherzer, Niels Seersholm, Robert A. Stockley, Jan Stolk, Maria Sucena, Hanan Tanash, Alice Turner, Ruxandra Ulmeanu, Marion Wilkens, Arzu Yorgancioğlu, Ana Zaharie, Marc Miravitlles
Publikováno v:
ERJ Open Research, Vol 6, Iss 1 (2020)
Rationale and objectives Alpha-1 antitrypsin deficiency (AATD) is a genetic condition that leads to an increased risk of emphysema and liver disease. Despite extensive investigation, there remain unanswered questions concerning the natural history, p
Externí odkaz:
https://doaj.org/article/19427942e70f4ec99e35aebb5bcf081f
Autor:
Ursel Soomets, Ragne Tamm, Triin Laurits, Viktoria Ivanova, Martin Juss, Egon Taalberg, Roman Pihlakas, Ketlin Veeväli, Birgit Ahas, Tuuliki Hion, Kalle Kilk, Ott Kiens, Alan Altraja
Publikováno v:
Sleep and control of breathing.
Autor:
Ott Kiens, Viktoria Ivanova, Egon Taalberg, Ketlin Veeväli, Ragne Tamm, Triin Laurits, Birgit Ahas, Martin Juss, Tuuliki Hion, Roman Pihlakas, Kalle Kilk, Ursel Soomets, Alan Altraja
Publikováno v:
Sleep and control of breathing.
Publikováno v:
Monitoring airway disease.
Autor:
Vibeke Backer, Christer Janson, Hannu Kankaanranta, Lauri Lehtimäki, Leif Bjermer, Rikke Dodge, Luisa Alvares, Celeste Porsbjerg, Apostolos Bossios, Hatef Darabi, Maria Lindh, Alan Altraja, Arja Viinanen, Paula Kauppi, Kirk Geale, Charlotte Suppli Ulrik
Publikováno v:
Airway pharmacology and treatment.
Background: Oral corticosteroids (OCS) may be used for treatment of severe asthma to achieve disease control. Nordic guidelines recommend low doses and short courses of treatment due to limited long-term efficacy and risk of adverse effects. Knowledg
Autor:
Ketlin Veeväli, Birgit Ahas, Egon Taalberg, Kalle Kilk, Alan Altraja, Ott Kiens, Roman Pihlakas, Triin Laurits, Ursel Soomets, Ragne Tamm, Tuuliki Hion, Martin Juss, Viktoria Ivanova
Publikováno v:
Sleep and control of breathing.